Company Filing History:

22 out of 42

Siegfried Aktiengesellschaft

patents

1 out of 1,678

Degussa Aktiengesellschaft

patents

1 out of 1

Siegfried Aktiengesselschaft

patent

Years Active: 1978-1987

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4668786 - P-fluorobenzoyl-piperidino alkyl theophylline derivatives (1987-05-26),

2. 4603204 - Theophylline derivatives (1986-07-29),

3. 4554356 - Method for production of imidazolyl vinyl ethers (1985-11-19),

4. 4554281 - 2-Amino-3-acylamino-6-benzylamino-pyridine-derivative having (1985-11-19),

5. 4550175 - Process for the stereospecific preparation of (1985-10-29),

6. 4526898 - Antihypertensive 4-(2-imidazolin-2-yl-amino)-2-methyl-indazole (1985-07-02),

7. 4483999 - Phenoxy alkanoic acid derivatives having the ability to lower the level (1984-11-20),

8. 4443612 - Process for the stereospecific preparation of imidazolyl oximes (1984-04-17),

9. 4436913 - 1H- and 2H- indazole derivatives (1984-03-13),

10. 4330545 - Heterocyclic imidazolyl vinyl ethers and use of same as fungicides or (1982-05-18),

11. 4305942 - Xanthine oxidase inhibitor and therapeutic treatment using same (1981-12-15),

12. 4275068 - Lipid lowering alkylene glycols and ester derivatives thereof (1981-06-23),

13. 4214095 - Chlorobenzyl phenoxy alkoxylates (1980-07-22),

14. 4211551 - Herbicide (1980-07-08),

15. 4210657 - Aryl imidazolyl vinyl ethers and processes for using same (1980-07-01),

Title: The Innovative Contributions of Kurt Thiele

Introduction: Kurt Thiele, a prolific inventor hailing from Zofingen, Switzerland, has made remarkable contributions to the field of pharmaceuticals with a total of 24 patents to his name. His work primarily focuses on derivatives of theophylline, showcasing his innovative approach to medicinal chemistry.

Latest Patents: Among his latest innovations are the P-fluorobenzoyl-piperidino alkyl theophylline derivatives, which display a variety of beneficial properties. These derivatives possess the formula wherein R is hydrogen or a hydroxy group, and n is an integer ranging from 0 to 3. The compounds exhibit histamine, serotonin, bradykinin antagonistic, anti-anaphylactic, and beta-adrenergic stimulating effects, making them significant in therapeutic applications. Additionally, Thiele's work on other theophylline derivatives further expands the landscape of pharmaceutical compounds, combining various functionalities in their structure. These exhibit similar properties and are composed of complex aryl or hetero-aryl rings, showcasing his depth of knowledge in chemistry and its applications.

Career Highlights: Kurt Thiele has collaborated with esteemed companies such as Siegfried AG and Degussa AG. His time at these organizations allowed him to refine his research and bring his innovative ideas to life in a commercial context.

Collaborations: Throughout his career, Thiele has worked alongside notable colleagues including Ulrich Jahn and Ludwig Zirngibl. These collaborations have enriched his research perspective and have certainly contributed to the successful development of his patented inventions.

Conclusion: Kurt Thiele's innovative work in pharmaceutical chemistry, particularly in the area of theophylline derivatives, underscores his contributions to the industry. His 24 patents reflect a commitment to advancing medical science through inventive solutions, leaving a lasting impact in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com